Jill Barber
Manchester University
H-index: 32
North America-United States
Top articles of Jill Barber
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver | Molecular Omics | Areti-Maria Vasilogianni Sarah Alrubia Eman El-Khateeb Zubida M Al-Majdoub Narciso Couto | 2024 |
Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc receptor (FcRn) in human tissues and implications for pharmacokinetic … | European Journal of Pharmaceutical Sciences | Jill Barber Zubida M Al-Majdoub Narciso Couto Martyn Howard Yasmine Elmorsi | 2023/3/1 |
Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis | Frontiers in Oncology | Areti-Maria Vasilogianni Zubida M Al-Majdoub Brahim Achour Sheila Annie Peters Amin Rostami-Hodjegan | 2023/2/20 |
Quantitative proteomics of pharmacokinetics (PK) and pharmacodynamics (PD) targets in liver, small intestine, colon, appendiceal and peritoneal cancer | AM Vasilogianni C Demonacos Omer Aziz SA Peters J Barber | 2023 | |
Challenges and Opportunities for In Vitro–In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation | Nihan Izat Jayaprakasam Bolleddula Armina Abbasi Lionel Cheruzel Robert S Jones | 2023/12/1 | |
Label-free but still constrained: assessment of global proteomic strategies for the quantification of hepatic enzymes and transporters | Drug Metabolism and Disposition | Jill Barber Zubida M Al-Majdoub Narciso Couto Areti-Maria Vasilogianni Annika Tillmann | 2022/6/1 |
Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters | Journal of Pharmaceutical Sciences | Sarah Alrubia Zubida M Al-Majdoub Brahim Achour Amin Rostami-Hodjegan Jill Barber | 2022/10/1 |
Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects | British Journal of Clinical Pharmacology | Areti‐Maria Vasilogianni Zubida M Al‐Majdoub Brahim Achour Sheila Annie Peters Amin Rostami‐Hodjegan | 2022/4 |
Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis | Clinical Pharmacology & Therapeutics | Areti‐Maria Vasilogianni Zubida M Al‐Majdoub Brahim Achour Sheila Annie Peters Jill Barber | 2022/9 |
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5′-Diphosphate … | Drug Metabolism and Disposition | Anika N Ahmed Amin Rostami-Hodjegan Jill Barber Zubida M Al-Majdoub | 2022/8/1 |
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease | Journal of Proteomics | Areti-Maria Vasilogianni Eman El-Khateeb Zubida M Al-Majdoub Sarah Alrubia Amin Rostami-Hodjegan | 2022/7/15 |
Computational Studies on Selected Macrolides Active against Escherichia coli Combined with the NMR Study of Tylosin A in Deuterated Chloroform | Molecules | Biljana Arsic Jill Barber Ana Cikos Manikandan Kadirvel Emilija Kostic | 2022/10/26 |
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins | Journal of Proteomics | Areti-Maria Vasilogianni Eman El-Khateeb Brahim Achour Sarah Alrubia Amin Rostami-Hodjegan | 2022/6/15 |
Altered bioavailability and pharmacokinetics in Crohn’s disease: Capturing systems parameters for PBPK to assist with predicting the fate of orally administered drugs | Sarah Alrubia Jialin Mao Yuan Chen Jill Barber Amin Rostami-Hodjegan | 2022/10 | |
American Society for Clinical Pharmacology and Therapeutics | Clinical Pharmacology & Therapeutics | EPITHELIAL HANDLING OF XENOBIOTICS Z Al N Majdoub B Couto M Harwood G Carlson | 2021/3/1 |
Non-uniformity of changes in drug-metabolizing enzymes and transporters in liver cirrhosis: implications for drug dosage adjustment | Molecular pharmaceutics | Eman El-Khateeb Brahim Achour Zubida M Al-Majdoub Jill Barber Amin Rostami-Hodjegan | 2021/8/24 |
Proteomic quantification of changes in abundance of drug-metabolizing enzymes and drug transporters in human liver cirrhosis: different methods, similar outcomes | Drug Metabolism and Disposition | Eman El-Khateeb Zubida M Al-Majdoub Amin Rostami-Hodjegan Jill Barber Brahim Achour | 2021/8/1 |
Liquid biopsy enables quantification of the abundance and interindividual variability of hepatic enzymes and transporters | Clinical Pharmacology & Therapeutics | Brahim Achour Zubida M Al‐Majdoub Agnieszka Grybos‐Gajniak Kristi Lea Peter Kilford | 2021/1 |
Label-free quantitative proteomics and substrate-based mass spectrometry imaging of xenobiotic metabolizing enzymes in ex vivo human skin and a human living skin equivalent model | Drug Metabolism and Disposition | Narciso Couto Jillian RA Newton Cristina Russo Esther Karunakaran Brahim Achour | 2021/1/1 |
Hepatic scaling factors for in vitro–in vivo extrapolation of metabolic drug clearance in patients with colorectal cancer with liver metastasis | Drug Metabolism and Disposition | Areti-Maria Vasilogianni Brahim Achour Daniel Scotcher Sheila Annie Peters Zubida M Al-Majdoub | 2021/7/1 |
Co-Authors
